Assyro AI

FDA Orange Book · active-ingredient family

Albuterol sulfate; budesonide

Albuterol sulfate; budesonide is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:AIRSUPRA · NDA 214070

1

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

2

Exclusivity periods

Brand (NDA) products · aerosol, metered

ProductApplicantApplicationTEApproved
AIRSUPRARLDASTRAZENECANDA 214070Jan 10, 2023

Marketing exclusivity (2)

  • M-317New use / labeling-change exclusivity (3 years)

    Sep 15, 2028

    in 2 yr 3 mo

  • NPNew product exclusivity (3 years)

    Jan 10, 2026

    5 mo ago

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9415009May 28, 2030in 4 yr
U-3509

Albuterol sulfate; budesonide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.